Disopyramide use in infants and children with hypertrophic cardiomyopathy
暂无分享,去创建一个
[1] B. Maron,et al. Hypertrophic Cardiomyopathy in Children, Adolescents, and Young Adults Associated With Low Cardiovascular Mortality With Contemporary Management Strategies , 2016, Circulation.
[2] M. Ackerman,et al. Surgical Ventricular Septal Myectomy for Patients With Noonan Syndrome and Symptomatic Left Ventricular Outflow Tract Obstruction. , 2015, The American journal of cardiology.
[3] J. Carlin,et al. Sudden death in childhood cardiomyopathy: results from a long-term national population-based study. , 2015, Journal of the American College of Cardiology.
[4] M. Sherrid,et al. Treatment of Obstructive Hypertrophic Cardiomyopathy Symptoms and Gradient Resistant to First-Line Therapy With &bgr;-Blockade or Verapamil , 2013, Circulation. Heart failure.
[5] M. Dick,et al. Verapamil in Infants: An Exaggerated Fear? , 2013, Pediatric Cardiology.
[6] S. Ommen,et al. Outcome of septal myectomy for obstructive hypertrophic cardiomyopathy in children and young adults. , 2013, The Annals of thoracic surgery.
[7] M. Sherrid,et al. A primer of disopyramide treatment of obstructive hypertrophic cardiomyopathy. , 2012, Progress in cardiovascular diseases.
[8] W. Williams,et al. Hypertrophic cardiomyopathy in childhood: disease natural history, impact of obstruction, and its influence on survival. , 2012, The Annals of thoracic surgery.
[9] Barry J Maron,et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, The Journal of thoracic and cardiovascular surgery.
[10] B. Maron,et al. Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. , 2005, Journal of the American College of Cardiology.
[11] Yohnosuke Kobayashi,et al. Effective disopyramide treatment in a boy with mid-ventricular hypertrophic obstructive cardiomyopathy. , 2002, Circulation journal : official journal of the Japanese Circulation Society.
[12] M. Sherrid,et al. Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy. , 1998, Circulation.
[13] M. Tyrrell,et al. Disopyramide as a negative inotrope in obstructive cardiomyopathy in children. , 1991, The Canadian journal of cardiology.
[14] D. Holt,et al. Measurement of plasma disopyramide as a guide to paediatric use. , 1986, International journal of cardiology.